Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The price of Kymera Therapeutics Inc (NASDAQ: KYMR) closed at $25.02 in the last session, down -1.73% from day before closing price of $25.46. In other words, the price has decreased by -$1.73 from its previous closing price. On the day, 0.72 million shares were traded. KYMR stock price reached its highest trading level at $25.46 during the session, while it also had its lowest trading level at $24.425.
Ratios:
We take a closer look at KYMR’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 7.53 and its Current Ratio is at 7.53. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on March 13, 2025, initiated with a Buy rating and assigned the stock a target price of $52.
On December 10, 2024, BTIG Research started tracking the stock assigning a Buy rating and target price of $60.
On December 06, 2024, BMO Capital Markets started tracking the stock assigning a Market Perform rating and target price of $55.BMO Capital Markets initiated its Market Perform rating on December 06, 2024, with a $55 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 03 ’25 when Chiniara Ellen sold 2,241 shares for $30.45 per share. The transaction valued at 68,239 led to the insider holds 80,085 shares of the business.
Chadwick Jeremy G sold 1,383 shares of KYMR for $42,113 on Mar 03 ’25. The Chief Operating Officer now owns 67,800 shares after completing the transaction at $30.45 per share. On Mar 03 ’25, another insider, Jacobs Bruce N., who serves as the Chief Financial Officer of the company, sold 7,035 shares for $30.45 each. As a result, the insider received 214,219 and left with 201,886 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KYMR now has a Market Capitalization of 1624901376 and an Enterprise Value of 1223919232. For the stock, the TTM Price-to-Sale (P/S) ratio is 34.52 while its Price-to-Book (P/B) ratio in mrq is 1.94. Its current Enterprise Value per Revenue stands at 26.001 whereas that against EBITDA is -4.881.
Stock Price History:
The Beta on a monthly basis for KYMR is 2.22, which has changed by -0.28758544 over the last 52 weeks, in comparison to a change of 0.05279863 over the same period for the S&P500. Over the past 52 weeks, KYMR has reached a high of $53.27, while it has fallen to a 52-week low of $19.44. The 50-Day Moving Average of the stock is -20.58%, while the 200-Day Moving Average is calculated to be -38.91%.
Shares Statistics:
According to the various share statistics, KYMR traded on average about 678.46K shares per day over the past 3-months and 1048510 shares per day over the past 10 days. A total of 64.89M shares are outstanding, with a floating share count of 53.88M. Insiders hold about 17.03% of the company’s shares, while institutions hold 95.05% stake in the company. Shares short for KYMR as of 1743379200 were 7990149 with a Short Ratio of 11.78, compared to 1740700800 on 7575085. Therefore, it implies a Short% of Shares Outstanding of 7990149 and a Short% of Float of 13.73.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
